Your browser doesn't support javascript.
loading
Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions.
Gilbert, Antoine; Tudor, Mihaela; Montanari, Juliette; Commenchail, Kevin; Savu, Diana Iulia; Lesueur, Paul; Chevalier, François.
Afiliação
  • Gilbert A; UMR6252 CIMAP, Team Applications in Radiobiology with Accelerated Ions, CEA-CNRS-ENSICAEN-Université de Caen Normandie, 14000 Caen, France.
  • Tudor M; Department of Life and Environmental Physics, Horia Hulubei National Institute of Physics and Nuclear Engineering, 077125 Magurele, Romania.
  • Montanari J; Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania.
  • Commenchail K; UMR6252 CIMAP, Team Applications in Radiobiology with Accelerated Ions, CEA-CNRS-ENSICAEN-Université de Caen Normandie, 14000 Caen, France.
  • Savu DI; UMR6252 CIMAP, Team Applications in Radiobiology with Accelerated Ions, CEA-CNRS-ENSICAEN-Université de Caen Normandie, 14000 Caen, France.
  • Lesueur P; Department of Life and Environmental Physics, Horia Hulubei National Institute of Physics and Nuclear Engineering, 077125 Magurele, Romania.
  • Chevalier F; Radiation Oncology Department, Centre François Baclesse, 14000 Caen, France.
Cancers (Basel) ; 15(7)2023 Mar 24.
Article em En | MEDLINE | ID: mdl-37046623
ABSTRACT
Chondrosarcoma is a malignant cartilaginous tumor that is particularly chemoresistant and radioresistant to X-rays. The first line of treatment is surgery, though this is almost impossible in some specific locations. Such resistances can be explained by the particular composition of the tumor, which develops within a dense cartilaginous matrix, producing a resistant area where the oxygen tension is very low. This microenvironment forces the cells to adapt and dedifferentiate into cancer stem cells, which are described to be more resistant to conventional treatments. One of the main avenues considered to treat this type of tumor is hadrontherapy, in particular for its ballistic properties but also its greater biological effectiveness against tumor cells. In this review, we describe the different forms of chondrosarcoma resistance and how hadrontherapy, combined with other treatments involving targeted inhibitors, could help to better treat high-grade chondrosarcoma.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article